Medical Device | December 09, 2021
B Medical Systems to invest Rs 100 cr. to manufacture medical cold chain equipment in Gujarat
An MoU was signed between B Medical Systems and Gujarat government recently
An MoU was signed between B Medical Systems and Gujarat government recently
Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19
The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
It’s a two-dose vaccine administered 28 days apart
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Subscribe To Our Newsletter & Stay Updated
